Hepatitis B virus-host interactions and novel targets for viral cure

Clicks: 185
ID: 273048
2021
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #3 of 3 articles by views in current opinion in virology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Chronic infection with HBV is a major cause of advanced liver disease and hepatocellular carcinoma. Nucleos(t)ide analogues effectively control HBV replication but viral cure is rare. Hence treatment has often to be administered for an indefinite duration, increasing the risk for selection of drug r …
Reference Key
g2021currenthepatitis Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Ligat G;Verrier ER;Nassal M;Baumert TF;;
Journal current opinion in virology
Year 2021
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/34029994
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't pmid:34029994 doi:10.1016/j.coviro.2021.04.009 gaëtan ligat eloi r verrier thomas f baumert

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.